Congressional hearing set to discuss country’s COVID-19 vaccine supply

A House Commerce subcommittee hearing is being held with COVID-19 vaccine manufacturers to discuss the country’s vaccine supply.A top executive with Johnson & Johnson is expected to tell lawmakers that the company can deliver 20 million doses of its single-shot vaccine by the end of March. The company said despite production concerns, they expect to pump out 100 million doses in the first half of this year, and it is ready to start shipping immediately. U.S. health regulators are still reviewing the safety and effectiveness of the shot and a decision to allow its emergency use is expected later this week. J&J’s vaccine would be the first in the U.S. that requires only a single shot.An FDA panel will meet Friday to consider the company’s request for emergency authorization. That means the shot could get the green light as early as this weekend. The House panel will also hear from Pfizer and Moderna on how production can be ramped up.

A House Commerce subcommittee hearing is being held with COVID-19 vaccine manufacturers to discuss the country’s vaccine supply.

A top executive with Johnson & Johnson is expected to tell lawmakers that the company can deliver 20 million doses of its single-shot vaccine by the end of March.

The company said despite production concerns, they expect to pump out 100 million doses in the first half of this year, and it is ready to start shipping immediately.

U.S. health regulators are still reviewing the safety and effectiveness of the shot and a decision to allow its emergency use is expected later this week. J&J’s vaccine would be the first in the U.S. that requires only a single shot.

An FDA panel will meet Friday to consider the company’s request for emergency authorization. That means the shot could get the green light as early as this weekend.

The House panel will also hear from Pfizer and Moderna on how production can be ramped up.

.